From the publishers of JADPRO

MPN Resource Center

Advertisement

Novel Concepts of Treatment for Patients with Myelofibrosis and Related Neoplasms

Experts in the field of myeloproliferative neoplasms review current therapies, including hydroxyurea, interferons, and JAK inhibitors, as well as their important benefits and limitations. In addition, they highlight treatments that have been studied as monotherapy in patients with myelofibrosis and novel compounds in development for polycythemia vera and essential thrombocythemia.

Cancers
Advertisement
News & Literature Highlights
Advertisement
Advertisement